 |
|
Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
Jae Hui Kim, Dong Won Lee, Sung Chan Choi, Jong Woo Kim, Tae Gon Lee, Chul Gu Kim, Han Joo Cho
Korean J Ophthalmol. 2015;29(6):404-410. Published online 2015 Nov 25 DOI: https://doi.org/10.3341/kjo.2015.29.6.404
|
|
Citations to this article as recorded by
 Update on medical and surgical management of submacular hemorrhage
Amy Q. Lu, Jay G. Prensky, Paul S. Baker, Ingrid U. Scott, Tamer H. Mahmoud, Bozho Todorich
Expert Review of Ophthalmology.2020; 15(1): 43. CrossRef Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
Xiaoya Gu, Xiaobing Yu, Hong Dai
BMC Ophthalmology.2019;[Epub] CrossRef Polypoidal choroidal vasculopathy treatment options: A meta-analysis
Tianwei Qian, Xinxin Li, Mengya Zhao, Xun Xu
European Journal of Clinical Investigation.2018; 48(1): e12840. CrossRef Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment
Kaiyan Zhang, Yingying Chen, Xuyang Sun, Qionglei Zhong, Lin Lin, Yuan Gao, Fanlin Hong
Medicine.2018; 97(39): e12464. CrossRef Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes
Hyun Ji Hwang, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim
Korean Journal of Ophthalmology.2017; 31(3): 230. CrossRef
|